Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lova Sun

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Clinical and Translational Radiation Oncology|December 3, 2025
Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective studyNikhil Yegya-Raman, Kyunga Ko, Ivy S Han, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With <i>ALK</i> or <i>ROS1</i>-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
JCO Oncology Practice|June 16, 2021
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumSarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical and Translational Radiation Oncology|December 3, 2025
Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective studyNikhil Yegya-Raman, Kyunga Ko, Ivy S Han, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With <i>ALK</i> or <i>ROS1</i>-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
JCO Oncology Practice|June 16, 2021
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumSarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 9